Virtus LifeSci Biotech Products ETF Rating $64.16 -0.26 (-0.40%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.81Holdings in BBP have an aggregate rating of Moderate Buy based on 615 analyst ratings issued in the past year covering 50 companies (86.9% of the portfolio).BBP Aggregate Price Target$95.8649.42% UpsideHigh Prediction$129.50Average Prediction$95.86Low Prediction$64.15Holdings in BBP have an aggregate price target of $95.86 and a range of $64.15 to $129.50 covering 50 companies (86.9% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy34 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.64%TVTXTravere Therapeutics$18.10+3.0%2.0882 of 5 stars2.85$21.85 20.7%13Earnings ReportAnalyst Forecast2.73%ALNYAlnylam Pharmaceuticals$269.95-1.4%3.806 of 5 stars2.75$294.50 9.1%24Earnings ReportAnalyst Forecast2.18%MIRMMirum Pharmaceuticals$40.45+0.1%4.4384 of 5 stars3.17$56.82 40.5%12Upcoming Earnings2.17%PHATPhathom Pharmaceuticals$18.94+3.7%1.5306 of 5 stars2.75$22.50 18.8%4Upcoming Earnings2.16%ADMAADMA Biologics$19.11-1.3%2.5836 of 5 stars3.25$15.50 -18.9%4Upcoming Earnings2.07%KNSAKiniksa Pharmaceuticals$21.48-4.4%2.6415 of 5 stars3.00$34.60 61.1%5Earnings Report2.06%ZLABZai Lab$30.89+1.4%2.864 of 5 stars3.00$52.50 70.0%42.05%TGTXTG Therapeutics$24.36-9.4%4.7875 of 5 stars2.83$36.33 49.2%6News CoverageGap DownHigh Trading Volume2.01%GILDGilead Sciences$89.84+0.4%4.9225 of 5 stars2.65$86.85 -3.3%23Upcoming Earnings1.94%EXELExelixis$34.29+0.5%4.6445 of 5 stars2.65$31.44 -8.3%20Earnings Report1.94%BGNEBeiGene$207.25+1.5%1.896 of 5 stars2.71$246.21 18.8%71.94%AUPHAurinia Pharmaceuticals$7.21-1.5%2.1381 of 5 stars2.75$10.00 38.7%4Upcoming Earnings1.93%RAREUltragenyx Pharmaceutical$51.06+0.1%4.2548 of 5 stars2.92$85.17 66.8%12Upcoming EarningsHigh Trading Volume1.93%LGNDLigand Pharmaceuticals$110.22+0.2%4.835 of 5 stars3.00$132.83 20.5%6Upcoming Earnings1.90%AXSMAxsome Therapeutics$87.25-1.8%4.7881 of 5 stars3.00$124.64 42.9%14Positive News1.89%UTHRUnited Therapeutics$376.80+0.7%4.6373 of 5 stars2.73$370.86 -1.6%15Earnings ReportAnalyst ForecastInsider SellingPositive News1.81%BCRXBioCryst Pharmaceuticals$7.35-12.8%4.0067 of 5 stars2.83$14.17 92.7%6News CoverageGap DownHigh Trading Volume1.79%IOVAIovance Biotherapeutics$11.44+2.2%3.6216 of 5 stars2.89$22.33 95.2%9Upcoming Earnings1.79%INSMInsmed$68.09-0.3%3.8444 of 5 stars3.00$83.07 22.0%16Earnings ReportAnalyst Forecast1.77%YMABY-mAbs Therapeutics$14.87+0.9%3.075 of 5 stars2.88$21.14 42.2%8Upcoming Earnings1.76%HRMYHarmony Biosciences$33.05-0.1%4.8905 of 5 stars2.56$47.00 42.2%9Earnings ReportHigh Trading Volume1.72%BNTXBioNTech$108.97-2.3%2.3319 of 5 stars2.71$135.46 24.3%14Analyst ForecastNews CoveragePositive News1.71%DAWNDay One Biopharmaceuticals$14.81+1.1%1.7717 of 5 stars2.88$35.71 141.1%8Earnings ReportAnalyst Revision1.69%RYTMRhythm Pharmaceuticals$52.99+8.1%3.6278 of 5 stars2.89$60.33 13.9%9Upcoming Earnings1.69%ITCIIntra-Cellular Therapies$86.17-0.4%4.5862 of 5 stars2.85$96.62 12.1%13Earnings ReportAnalyst ForecastAnalyst Revision1.68%LXRXLexicon Pharmaceuticals$1.21-0.8%1.8833 of 5 stars2.75$8.00 563.9%4Gap Down1.65%FOLDAmicus Therapeutics$11.33-1.2%4.432 of 5 stars2.89$17.13 51.1%9Upcoming Earnings1.63%TARSTarsus Pharmaceuticals$46.21-2.3%1.3901 of 5 stars3.00$51.60 11.7%71.63%ROIVRoivant Sciences$11.53-1.3%3.115 of 5 stars2.90$17.39 50.8%10Upcoming Earnings1.59%AMGNAmgen$316.91-0.7%4.5092 of 5 stars2.50$333.50 5.2%24Earnings ReportAnalyst UpgradeAnalyst Revision1.56%HALOHalozyme Therapeutics$58.47+2.3%4.7099 of 5 stars2.60$61.00 4.3%10Analyst Forecast1.56%INCYIncyte$75.75-0.5%4.0866 of 5 stars2.38$76.74 1.3%21Earnings Report1.56%PTCTPTC Therapeutics$40.39-0.2%2.7503 of 5 stars2.33$40.08 -0.8%15Upcoming Earnings1.51%TBPHTheravance Biopharma$8.21-0.8%1.688 of 5 stars2.40$13.75 67.5%51.50%ASNDAscendis Pharma A/S$125.77+0.4%3.1577 of 5 stars2.92$195.92 55.8%13Upcoming EarningsAnalyst ForecastNews Coverage1.50%ACADACADIA Pharmaceuticals$14.62-1.3%4.5114 of 5 stars2.65$25.56 74.8%17Upcoming Earnings1.50%SRPTSarepta Therapeutics$123.07-0.2%4.9474 of 5 stars2.95$182.95 48.7%21Upcoming EarningsPositive News1.49%VRTXVertex Pharmaceuticals$472.80+0.4%3.3118 of 5 stars2.48$492.50 4.2%291.45%LEGNLegend Biotech$43.61-1.7%2.0361 of 5 stars3.00$82.08 88.2%141.45%KRYSKrystal Biotech$170.85-3.1%4.6808 of 5 stars3.00$196.75 15.2%9News CoverageGap DownHigh Trading Volume1.44%AGIOAgios Pharmaceuticals$44.83-0.1%4.3275 of 5 stars2.50$52.33 16.7%8Analyst Forecast1.43%REGNRegeneron Pharmaceuticals$828.84-1.7%4.8372 of 5 stars2.71$1,097.25 32.4%21Analyst Forecast1.42%IONSIonis Pharmaceuticals$38.44-0.8%4.2378 of 5 stars2.68$61.00 58.7%19Upcoming EarningsAnalyst Upgrade1.35%DVAXDynavax Technologies$11.79+0.1%4.5498 of 5 stars2.67$22.00 86.6%3Upcoming Earnings1.33%ARDXArdelyx$5.89-3.3%4.192 of 5 stars3.00$11.67 98.1%8Analyst ForecastOptions VolumeAnalyst Revision1.32%BBIOBridgeBio Pharma$25.20-1.1%4.6402 of 5 stars2.87$47.50 88.5%15Upcoming Earnings1.28%NBIXNeurocrine Biosciences$120.53-1.4%4.9154 of 5 stars2.83$163.91 36.0%24Analyst ForecastAnalyst Revision1.28%IMCRImmunocore$31.17-1.7%1.8307 of 5 stars2.69$74.36 138.6%13Upcoming Earnings1.24%GERNGeron$4.25+3.4%3.945 of 5 stars3.00$6.94 63.4%10Upcoming Earnings1.23%BMRNBioMarin Pharmaceutical$66.01-0.9%4.9666 of 5 stars2.67$94.16 42.6%21Earnings ReportAnalyst Revision This page (NYSEARCA:BBP) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
